Template:Endothelial antihypertensives/ja: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Navbox | name = Sympatholytic antihypertensives | title = Sympatholytic (and closely related) antihypertensives (C02) | state = {{{state<includeonly>|autocollapse</includeonly>}}} | listclass = hlist | group1 = Sympatholytics<br />(antagonize α-adrenergic<br />vasoconstriction) | list1 = {{Navbox|child | group1 = Central | list1 = {{Navbox|child | group1 = Alpha-adrenergic..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| name = Sympatholytic antihypertensives | | name = Sympatholytic antihypertensives/ja | ||
| title = [[Sympatholytic]] | | title = [[Sympatholytic/ja|交感神経遮断薬]]（および密接に関連した）[[antihypertensive/ja|抗高血圧薬]] ([[ATC code C02/ja|C02]]) | ||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | ||
| listclass = hlist | | listclass = hlist | ||
| group1 = [[Sympatholytic]] | | group1 = [[Sympatholytic/ja|交感神経遮断薬]]<br />(拮抗薬 [[Adrenergic receptor/ja#.CE.B1 receptors|α-アドレナリン]]<br />[[vasoconstriction/ja|血管収縮]]) | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
| Line 11: | Line 11: | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α<sub>2</sub>- | | group1 = [[Alpha-adrenergic agonist/ja#.CE.B12 agonists|α<sub>2</sub>-アドレナリン受容体作動薬]]s | ||
| list1 = | | list1 = | ||
* [[Clonidine]] | * [[Clonidine/ja]] | ||
* [[Guanabenz]] | * [[Guanabenz/ja]] | ||
* [[Guanfacine]] | * [[Guanfacine/ja]] | ||
* [[Guanoxabenz]] | * [[Guanoxabenz/ja]] | ||
* [[Methyldopa]]<sup>#</sup> | * [[Methyldopa/ja]]<sup>#</sup> | ||
* [[Tiamenidine]]<sup>‡</sup> | * [[Tiamenidine/ja]]<sup>‡</sup> | ||
| group2 = [[Adrenergic release inhibitor]] | | group2 = [[Adrenergic release inhibitor/ja|アドレナリン放出抑制剤]] | ||
| list2 = | | list2 = | ||
* [[Bethanidine]] | * [[Bethanidine/ja]] | ||
* [[Bretylium]] | * [[Bretylium/ja]] | ||
* [[Debrisoquine]] | * [[Debrisoquine/ja]] | ||
* [[Guanadrel]] | * [[Guanadrel/ja]] | ||
* [[Guanazodine]] | * [[Guanazodine/ja]] | ||
* [[Guancydine]] | * [[Guancydine/ja]] | ||
* [[Guanethidine]] | * [[Guanethidine/ja]] | ||
* [[Guanoclor]] | * [[Guanoclor/ja]] | ||
* [[Guanoxan]] | * [[Guanoxan/ja]] | ||
| group3 = [[Imidazoline receptor]] | | group3 = [[Imidazoline receptor/ja|イミダゾリン受容体]]作動薬 | ||
| list3 = | | list3 = | ||
* [[Moxonidine]] | * [[Moxonidine/ja]] | ||
* [[Rilmenidine]] | * [[Rilmenidine/ja]] | ||
* [[Tolonidine]] | * [[Tolonidine/ja]] | ||
| group4 = [[Ganglionic blocker| | | group4 = [[Ganglionic blocker/ja|神経節遮断]]/[[nicotinic antagonist/ja|ニコチン拮抗薬]] | ||
| list4 = | | list4 = | ||
* [[Hexamethonium]]<sup>‡</sup> | * [[Hexamethonium/ja]]<sup>‡</sup> | ||
* [[Mecamylamine]] | * [[Mecamylamine/ja]] | ||
* [[Pentolinium]] | * [[Pentolinium/ja]] | ||
* [[Trimetaphan camsilate| | * [[Trimetaphan camsilate/ja|トリメタファン]] | ||
}} | }} | ||
| group2 = | | group2 = 周辺 | ||
| list2 = {{Navbox|child | | list2 = {{Navbox|child | ||
| group1 = | | group1 = 間接的 | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
| group1 = [[Monoamine oxidase inhibitor]] | | group1 = [[Monoamine oxidase inhibitor/ja]] | ||
| list1 = | | list1 = | ||
* [[Pargyline]]<sup>‡</sup> | * [[Pargyline/ja]]<sup>‡</sup> | ||
| group2 = [[VMAT inhibitor]] | | group2 = [[VMAT inhibitor/ja]] | ||
| list2 = | | list2 = | ||
* [[Bietaserpine]] | * [[Bietaserpine/ja]] | ||
* [[Deserpidine]] | * [[Deserpidine/ja]] | ||
* [[Methoserpidine]] | * [[Methoserpidine/ja]] | ||
* [[Reserpine]] | * [[Reserpine/ja]] | ||
* [[Syrosingopine]] | * [[Syrosingopine/ja]] | ||
| group3 = [[Tyrosine hydroxylase inhibitor]] | | group3 = [[Tyrosine hydroxylase inhibitor/ja]] | ||
| list3 = | | list3 = | ||
* [[Metirosine]] | * [[Metirosine/ja]] | ||
}} | }} | ||
| group2 = | | group2 = 直接的 | ||
| list2 = {{Navbox|child | | list2 = {{Navbox|child | ||
| group1 = [[Alpha-1 blocker|α<sub>1</sub>- | | group1 = [[Alpha-1 blocker/ja|α<sub>1</sub>-アドレナリン受容体遮断薬]] | ||
| list1 = | | list1 = | ||
* [[Doxazosin]] | * [[Doxazosin/ja]] | ||
* [[Ketanserin]] | * [[Ketanserin/ja]] | ||
* [[Indoramin]] | * [[Indoramin/ja]] | ||
* [[Prazosin]] | * [[Prazosin/ja]] | ||
* [[Trimazosin]] | * [[Trimazosin/ja]] | ||
* [[Urapidil]] | * [[Urapidil/ja]] | ||
| group2 = [[Alpha blocker| | | group2 = [[Alpha blocker/ja|非選択性α-アドレナリン受容体遮断薬]] | ||
| list2 = | | list2 = | ||
* [[Phentolamine]] | * [[Phentolamine/ja]] | ||
}} | }} | ||
| Line 91: | Line 91: | ||
}} | }} | ||
| group2 = | | group2 = その他 [[Receptor antagonist/ja|拮抗薬]] | ||
| list2 = {{Navbox|child | | list2 = {{Navbox|child | ||
| group1 = [[Serotonin receptor antagonist]] | | group1 = [[Serotonin receptor antagonist/ja]] | ||
| list1 = | | list1 = | ||
* [[Ketanserin]] | * [[Ketanserin/ja]] | ||
* [[Lidanserin]] | * [[Lidanserin/ja]] | ||
| group2 = [[Endothelin receptor antagonist]] | | group2 = [[Endothelin receptor antagonist/ja]] ({{Abbrlink|PH|Pulmonary hypertension/ja}}用) | ||
| list2 = | | list2 = | ||
* '' | * ''デュアル'' ([[Bosentan/ja]], [[Macitentan/ja]]) | ||
* '' | * ''選択的'' ([[Ambrisentan/ja]], [[Sitaxentan/ja]]) | ||
}} | }} | ||
| belowstyle = background: transparent; padding: 0px; | | belowstyle = background: transparent; padding: 0px; | ||
| below = {{PharmNavFootnote}} | | below = {{PharmNavFootnote/ja}} | ||
}}<noinclude> | }}<noinclude> | ||
Latest revision as of 09:19, 5 November 2023
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Endothelial antihypertensives|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Endothelial antihypertensives|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Endothelial antihypertensives|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.